Physician profile
Corey Decker
NPI 1255070017
$639.34
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $268 · 2023: $254 · 2024: $118.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $372.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $371.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $96.28 | 2022-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $95.38 | 2022-2023 | |
| Medtronic, INC. | $91.14 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $71.28 | 2022-2024 | Jardiance |
| Atricure, INC. | $61.75 | 2023 | |
| Pfizer INC. | $43.52 | 2023-2024 | |
| Philips North America LLC | $43.23 | 2024 | (Ck7) Extended Holter |
| Merck Sharp & Dohme LLC | $37.72 | 2022-2023 | Verquvo |
| Sanofi-Aventis U.S. LLC | $27.46 | 2023 | |
| Astrazeneca Pharmaceuticals Lp | $25.50 | 2022-2023 | Brilinta |
| Baxter Healthcare | $17.37 | 2024 | Hillrom - Cardiac Ambulatory Monitor |
| Bardy Diagnostics, INC. | $15.32 | 2022 | |
| Biosense Webster, INC. | $13.39 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Corey Decker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.